Labcorp CFO exercises RSUs, withholds shares for tax

Labcorp Holdings Inc. Chief Financial Officer and EVP Julia Aijun Wang exercised previously granted restricted stock units, receiving 860 shares of common stock on February 11, 2026.

Rhea-AI Filing Summary

Labcorp Holdings Inc. Chief Financial Officer and EVP Julia Aijun Wang exercised previously granted restricted stock units, receiving 860 shares of common stock on February 11, 2026. Each unit converts into one share of common stock.

To cover tax withholding obligations, 245 shares of common stock were withheld at a price of $289.89 per share. After these transactions, Wang directly holds 1,817.239 shares of common stock and 4,964 restricted stock units, which continue to vest in three equal annual installments beginning February 11, 2026.

Insider Trade Summary

860 shares exercised/converted

Exercise 3 txns

Insider Wang Julia Aijun

Role Chief Financial Officer, EVP

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	860	$0.00	$0.00
Exercise	Common Stock	860	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	245	$289.89	$71K

Holdings After Transaction: Restricted Stock Unit — 4,964 contracts (Direct); Common Stock — 1,817.239 shares (Direct)

Footnotes (4)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. Stock withholding to satisfy tax withholding obligations.
3. F3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.
4. F4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) report for CFO Julia Aijun Wang?

Labcorp reported that CFO Julia Aijun Wang exercised 860 restricted stock units into common shares. These units convert one-for-one into Labcorp common stock, increasing her direct share ownership while reflecting scheduled vesting from a prior equity grant.

How many Labcorp (LH) shares were withheld for taxes in this Form 4?

A total of 245 Labcorp common shares were withheld to cover tax obligations at a price of $289.89 per share. This tax-withholding disposition is coded as an “F” transaction and did not represent an open-market sale by the executive.

How many Labcorp (LH) shares does the CFO own after this transaction?

After the reported transactions, CFO Julia Aijun Wang directly holds 1,817.239 shares of Labcorp common stock. This figure reflects the 860 shares received from restricted stock unit conversion, net of the 245 shares withheld to satisfy tax withholding obligations.

What is the status of the CFO’s restricted stock units at Labcorp (LH)?

Following the conversion, Wang holds 4,964 restricted stock units in Labcorp. These units come from a grant that vests in three equal annual installments beginning on February 11, 2026, providing additional future potential common stock upon each vesting date.

What do Labcorp (LH) restricted stock units represent in this filing?

Each restricted stock unit represents the contingent right to receive one share of Labcorp common stock. When units vest and are settled, they convert into common shares, as reflected by the 860-share derivative conversion reported for CFO Julia Aijun Wang on February 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 01:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wang Julia Aijun

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer, EVP

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		860	A	(1)	2,062.239	D
Common Stock	02/11/2026		F(2)		245	D	$289.89	1,817.239	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			860	(3)	(3)	Common Stock	860	$0	4,964(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.